FFA
THTX

Farther Finance Advisors’s Theratechnologies THTX Stock Holding History

Farther Finance Advisors’s Portfolio THTX Stock Details THTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-150
Closed -$186 – 4142
2024
Q3 		$186 Hold
150
– – ﹤0.01% 3668
2024
Q2 		$210 Hold
150
– – ﹤0.01% 3487
2024
Q1 		$236 Buy
+150
New +$241 ﹤0.01% 3231

Other funds holding THTX

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return

Farther Finance Advisors's THTX Position: Q4 2024 in Review

Farther Finance Advisors sold out of Theratechnologies (THTX) in Q4 2024, closing a stake of 150 shares — an estimated $186 sold.

Farther Finance Advisors first reported a position in THTX in Q1 2024 and held it in 3 quarters. The position peaked at $236 in Q1 2024. 41 funds tracked by Wall St. Rank hold THTX as of Q4 2024.

  • Farther Finance Advisors reported no remaining Theratechnologies position as of Q4 2024 after selling out during the quarter.
  • Farther Finance Advisors sold 150 Theratechnologies shares in Q4 2024, an estimated $186.
  • Farther Finance Advisors first reported a position in Theratechnologies in Q1 2024 and held it in 3 quarters.
  • Farther Finance Advisors's Theratechnologies position peaked at $236 in Q1 2024.
  • 41 funds tracked by Wall St. Rank held Theratechnologies as of Q4 2024.

Based on Farther Finance Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.